Earnings Call · Q3 FY2022·2022-11-03

Q3 22EPS +15.79%·Rev n/aQ2 22EPS +13.95%·Rev n/aQ1 22EPS +2.22%·Rev n/aQ4 21EPS +4.44%·Rev n/a⚠ consensus missing

Adaptive Biotechnologies Corp ADPT

Karina Calzadilla — Investor Relations

Chad Robins — Chief Executive Officer

Tycho Peterson — Chief Financial Officer

−0.9%1d on move date+0.1% vs SPY3d−3.4%5d−7.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADPT calls or request research access.

More ADPT calls Browse calls Request research access